Abstract

Mysteries of type I IFN response: benefits versus detriments.

Highlights

  • The original research performed by Babb et al investigates the potential adjuvant activity of gamma-irradiated influenza [1]

  • They demonstrate that co-vaccination with gamma-irradiatedinfluenza virus and poorly immunogenic inactivated Semliki forest virus (SFV) results in enhanced SFV-specific antibody responses without compromising humoral immunity against influenza infections

  • These authors speculate that gamma-irradiated influenza virus may be exploited as an adjuvant to improve the efficacy of poorly immunogenic vaccines owing to its ability to stimulate IFN-I production

Read more

Summary

Introduction

The original research performed by Babb et al investigates the potential adjuvant activity of gamma-irradiated influenza [1]. It is likely that the adjuvant activity of gamma-irradiated influenza virus is attributable to its potency of IFN-I induction. These authors speculate that gamma-irradiated influenza virus may be exploited as an adjuvant to improve the efficacy of poorly immunogenic vaccines owing to its ability to stimulate IFN-I production.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call